Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Wilkes

Showing results (1-10 of 276) with videos related to

Pageof 28
Sort By:
Medical Education|December 21, 2000
Medical students with developmental disabilitiesM Wilkes
Medical Education|September 21, 2001
Changing clinical practiceM Wilkes
Endocrinology|April 1, 1987
Reduced glomerular angiotensin II receptor density in diabetes mellitus in the rat: time course and mechanismB M Wilkes
Home Healthcare Nurse|September 1, 1992
Polypharmacy: dangers of multiple-drug therapy in patients with human immunodeficiency virus infectionG M Wilkes
Oncology (Williston Park, N.Y.)|October 29, 2009
New mTOR inhibitor for renal cell cancerGail M Wilkes
Asia-Pacific Journal of Oncology Nursing|April 3, 2018
Targeted Therapy: Attacking Cancer with Molecular and Immunological Targeted AgentsGail M Wilkes
Oncology (Williston Park, N.Y.)|February 1, 2011
Cabazitaxel, a taxane for men with hormone-refractory metastatic prostate cancerGail M Wilkes
Oncology (Williston Park, N.Y.)|October 28, 2009
Drug essentials mTOR inhibitorsGail M Wilkes
Oncology (Williston Park, N.Y.)|October 28, 2009
LevoleucovorinGail M Wilkes
Oncology (Williston Park, N.Y.)|November 7, 2014
Vismodegib, a hedgehog pathway inhibitor for adults with locally advanced or metastatic basal cell carcinomaGail M Wilkes
Pageof 28

Showing results (1-10 of 276) with videos related to

Sort By:
Pageof 28
Medical Education|December 21, 2000
Medical students with developmental disabilitiesM Wilkes
Medical Education|September 21, 2001
Changing clinical practiceM Wilkes
Endocrinology|April 1, 1987
Reduced glomerular angiotensin II receptor density in diabetes mellitus in the rat: time course and mechanismB M Wilkes
Home Healthcare Nurse|September 1, 1992
Polypharmacy: dangers of multiple-drug therapy in patients with human immunodeficiency virus infectionG M Wilkes
Oncology (Williston Park, N.Y.)|October 29, 2009
New mTOR inhibitor for renal cell cancerGail M Wilkes
Asia-Pacific Journal of Oncology Nursing|April 3, 2018
Targeted Therapy: Attacking Cancer with Molecular and Immunological Targeted AgentsGail M Wilkes
Oncology (Williston Park, N.Y.)|February 1, 2011
Cabazitaxel, a taxane for men with hormone-refractory metastatic prostate cancerGail M Wilkes
Oncology (Williston Park, N.Y.)|October 28, 2009
Drug essentials mTOR inhibitorsGail M Wilkes
Oncology (Williston Park, N.Y.)|October 28, 2009
LevoleucovorinGail M Wilkes
Oncology (Williston Park, N.Y.)|November 7, 2014
Vismodegib, a hedgehog pathway inhibitor for adults with locally advanced or metastatic basal cell carcinomaGail M Wilkes
Pageof 28